DoseEdge is the pharmacy workflow management tool that verifies the use of correct drugs, diluents and concentrations in the compounding of IV, chemo, TPN and oral liquid doses.
Baxa claimed that DoseEdge has achieved a major milestone in the advancement of sterile dose compounding, having processed more than 5 million safe doses since its market introduction.
Baxa said that with this release, version 2010.2 of the software, users can now extend DoseEdge safety benefits to a wider variety of compounded dose types through the application of a greatly expanded formulary database.
Improvements and new functionality added to the DoseEdge Pharmacy Workflow Manager in version 2010.2 include FormularyPlus which allows DoseEdge to identify more than 14,000 drug products via barcode scanning, and provides a process for easy maintenance and adding new products as information becomes available.
Additionally, the improved version also includes, oral liquid dose types, an addition of 9,000 new drug products to the formulary database extends DoseEdge safety benefits to the preparation of unit-dose oral liquids, with cost benefits for users of the Baxa ExactaMed line of oral syringes, improved overfill handling, improved email alerts and new windows support.
Baxa product manager Larry Gibson said that DoseEdge is the only dose management software that delivers compounding workflow management and error prevention for such a variety of dose types.